PYC THERAPEUTICS LIM

PYC

End-of-day quote - 01/19
0.15AUD	-3.23%

Prev.	0.1550
Open	0.1550
High	0.1600
Low	0.1500
Volume	1 651 728

12/10	PYC Therapeutics Names CEO of US Operations
11/12	PYC Therapeutics Raises $4 Million from Retail Entitlement Offer for Drug...
10/22	PYC THERAPEUTICS LIMITED : RIGHTS ISSUE: 0.1 new shares @ 0.17 AUD for 1...
11/2019	PHYLOGICA LIMITED : RIGHTS ISSUE: 1 new share @ 0.055 AUD for 5 existing shares

	Short Term	Mid-Term	Long Term
Trend	Neutral	Neutral	Bullish
Resistance	0,16	0,20	0,19
Spread/Res.	-6,3%	-23%	-19%
Spread/Supp.	7,1%	36%	58%
Support	0,14	0,11	0,10

Sales 2020	0,06 M 0,05 M 0,05 M
Net income 2020	-6,82 M -5,27 M -5,27 M
Net cash 2020	24,6 M 19,0 M 19,0 M
P/E ratio 2020	-46,3x
Yield 2020	-

Capitalization	476 M 366 M 367 M
EV / Sales 2019	258 646x
EV / Sales 2020	5 000x
Nbr of Employees	5
Free-Float	36,0%

PYC Therapeutics Limited, formerly Phylogica Limited, is a pharmaceutical company. The Company is engaged combining its cell-penetrating peptides (CPP) technology with in ASOs to create a pipeline of drugs called CPP-ASOs. The Company intends to expand its pipeline to include other disease...

>> Read more

Sector :

Biotechnology & Medical Research - NEC

Calendar :

2021-02-26 Earnings Release